Wuqiang Zhu, Ph.D. - Publications

2007 Indiana University, Bloomington, Bloomington, IN, United States 
Physiology Biology

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Zhu W, Reuter S, Field LJ. Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity. Cardiovascular Research. PMID 30423020 DOI: 10.1093/Cvr/Cvy273  0.44
2018 Wang J, Shen T, Zhu W, Dou L, Gu H, Zhang L, Yang Z, Chen H, Zhou Q, Sanchez ER, Field L, Mayo LD, Xie Z, Xiao D, Lin X, et al. Protein phosphatase 5 and the tumor suppressor P53 down-regulate each other's activities in mice. The Journal of Biological Chemistry. PMID 30262665 DOI: 10.1074/Jbc.Ra118.004256  0.4
2017 Toischer K, Zhu W, Hünlich M, Mohamed BA, Khadjeh S, Reuter SP, Schäfer K, Ramanujam D, Engelhardt S, Field LJ, Hasenfuss G. Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload. The Journal of Clinical Investigation. PMID 29083322 DOI: 10.1172/Jci81870  0.44
2015 Zhang W, Qu X, Chen B, Snyder M, Wang M, Li B, Tang Y, Chen H, Zhu W, Zhan L, Yin N, Li D, Li X, Liu Y, Zhang JJ, et al. Critical Roles of STAT3 in β-Adrenergic Functions in the Heart. Circulation. PMID 26628621 DOI: 10.1161/Circulationaha.115.017472  0.4
2014 Zhu W, Zhang W, Shou W, Field LJ. P53 inhibition exacerbates late-stage anthracycline cardiotoxicity. Cardiovascular Research. 103: 81-9. PMID 24812279 DOI: 10.1093/Cvr/Cvu118  0.44
2013 Chen H, Zhang W, Sun X, Yoshimoto M, Chen Z, Zhu W, Liu J, Shen Y, Yong W, Li D, Zhang J, Lin Y, Li B, VanDusen NJ, Snider P, et al. Fkbp1a controls ventricular myocardium trabeculation and compaction by regulating endocardial Notch1 activity. Development (Cambridge, England). 140: 1946-57. PMID 23571217 DOI: 10.1242/Dev.089920  0.44
2013 Zhu W, Soonpaa MH, Zhang W, Shou W, Payne M, Field LJ. Abstract 5602: Cyclin D2- mediated cardiomyocyte cell cycle activity reverses doxorubicin-induced cardiotoxicity. Cancer Research. 73: 5602-5602. DOI: 10.1158/1538-7445.Am2013-5602  0.44
2012 Choi EK, Chang PC, Lee YS, Lin SF, Zhu W, Maruyama M, Fishbein MC, Chen Z, Rubart-von der Lohe M, Field LJ, Chen PS. Triggered firing and atrial fibrillation in transgenic mice with selective atrial fibrosis induced by overexpression of TGF-β1. Circulation Journal : Official Journal of the Japanese Circulation Society. 76: 1354-62. PMID 22447020 DOI: 10.1253/Circj.Cj-11-1301  0.44
2012 Zaruba MM, Zhu W, Soonpaa MH, Reuter S, Franz WM, Field LJ. Granulocyte colony-stimulating factor treatment plus dipeptidylpeptidase-IV inhibition augments myocardial regeneration in mice expressing cyclin D2 in adult cardiomyocytes. European Heart Journal. 33: 129-37. PMID 21849352 DOI: 10.1093/Eurheartj/Ehr302  0.44
2012 Zhu W, Reuter S, Zhang W, Wagner GR, Payne RM, Caldwell RL, Shou W, Field LJ. Abstract 2500: The pivotal role of p53 in doxorubicin-induced acute versus chronic cardiotoxicity Cancer Research. 72: 2500-2500. DOI: 10.1158/1538-7445.Am2012-2500  0.44
2011 Zhang W, Chen H, Wang Y, Yong W, Zhu W, Liu Y, Wagner GR, Payne RM, Field LJ, Xin H, Cai CL, Shou W. Tbx20 transcription factor is a downstream mediator for bone morphogenetic protein-10 in regulating cardiac ventricular wall development and function. The Journal of Biological Chemistry. 286: 36820-9. PMID 21890625 DOI: 10.1074/Jbc.M111.279679  0.44
2011 Li D, Liu Y, Maruyama M, Zhu W, Chen H, Zhang W, Reuter S, Lin SF, Haneline LS, Field LJ, Chen PS, Shou W. Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy. Human Molecular Genetics. 20: 4582-96. PMID 21880664 DOI: 10.1093/Hmg/Ddr392  0.44
2011 Maruyama M, Li BY, Chen H, Xu X, Song LS, Guatimosim S, Zhu W, Yong W, Zhang W, Bu G, Lin SF, Fishbein MC, Lederer WJ, Schild JH, Field LJ, et al. FKBP12 is a critical regulator of the heart rhythm and the cardiac voltage-gated sodium current in mice. Circulation Research. 108: 1042-52. PMID 21372286 DOI: 10.1161/Circresaha.110.237867  0.44
2011 Li D, Hallett MA, Zhu W, Rubart M, Liu Y, Yang Z, Chen H, Haneline LS, Chan RJ, Schwartz RJ, Field LJ, Atkinson SJ, Shou W. Dishevelled-associated activator of morphogenesis 1 (Daam1) is required for heart morphogenesis. Development (Cambridge, England). 138: 303-15. PMID 21177343 DOI: 10.1242/Dev.055566  0.44
2011 Toischer K, Rokita AG, Unsöld B, Sossalla S, Becker A, Seidler T, Grebe C, Preuß L, Gupta SN, Schmidt K, Lehnart SE, Schäfer K, Maier LS, Hasenfuss G, Zhu W, et al. Response to letter regarding article, "differential Cardiac Remodeling in Preload Versus Afterload" Circulation. 123: e421. DOI: 10.1161/Circulationaha.110.017566  0.44
2010 Toischer K, Rokita AG, Unsöld B, Zhu W, Kararigas G, Sossalla S, Reuter SP, Becker A, Teucher N, Seidler T, Grebe C, Preuss L, Gupta SN, Schmidt K, Lehnart SE, et al. Differential cardiac remodeling in preload versus afterload. Circulation. 122: 993-1003. PMID 20733099 DOI: 10.1161/Circulationaha.110.943431  0.44
2009 Zhu W, Hassink RJ, Rubart M, Field LJ. Cell-cycle-based strategies to drive myocardial repair. Pediatric Cardiology. 30: 710-5. PMID 19340478 DOI: 10.1007/S00246-009-9408-3  0.44
2009 Zhu W, Soonpaa MH, Chen H, Shen W, Payne RM, Liechty EA, Caldwell RL, Shou W, Field LJ. Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway. Circulation. 119: 99-106. PMID 19103993 DOI: 10.1161/Circulationaha.108.799700  0.44
2009 Chen Q, Chen H, Zheng D, Kuang C, Fang H, Zou B, Zhu W, Bu G, Jin T, Wang Z, Zhang X, Chen J, Field LJ, Rubart M, Shou W, et al. Smad7 is required for the development and function of the heart. The Journal of Biological Chemistry. 284: 292-300. PMID 18952608 DOI: 10.1074/Jbc.M807233200  0.44
2008 Zhu W, Shou W, Payne RM, Caldwell R, Field LJ. A mouse model for juvenile doxorubicin-induced cardiac dysfunction. Pediatric Research. 64: 488-94. PMID 18614963 DOI: 10.1203/Pdr.0B013E318184D732  0.44
2008 Xu X, Sarikas A, Dias-Santagata DC, Dolios G, Lafontant PJ, Tsai SC, Zhu W, Nakajima H, Nakajima HO, Field LJ, Wang R, Pan ZQ. The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. Molecular Cell. 30: 403-14. PMID 18498745 DOI: 10.1016/J.Molcel.2008.03.009  0.44
2008 Shen WH, Chen Z, Shi S, Chen H, Zhu W, Penner A, Bu G, Li W, Boyle DW, Rubart M, Field LJ, Abraham R, Liechty EA, Shou W. Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mTOR-mediated signaling and cardiac function. The Journal of Biological Chemistry. 283: 13842-9. PMID 18326485 DOI: 10.1074/Jbc.M801510200  0.44
2007 Dowell JD, Tsai SC, Dias-Santagata DC, Nakajima H, Wang Z, Zhu W, Field LJ. Expression of a mutant p193/CUL7 molecule confers resistance to MG132- and etoposide-induced apoptosis independent of p53 or Parc binding. Biochimica Et Biophysica Acta. 1773: 358-66. PMID 17229476 DOI: 10.1016/J.Bbamcr.2006.11.020  0.44
2006 Chen H, Yong W, Ren S, Shen W, He Y, Cox KA, Zhu W, Li W, Soonpaa M, Payne RM, Franco D, Field LJ, Rosen V, Wang Y, Shou W. Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth. The Journal of Biological Chemistry. 281: 27481-91. PMID 16798733 DOI: 10.1074/Jbc.M604818200  0.44
Show low-probability matches.